Total Payments
$11,775
2024 Payments
$1,130
Companies
39
Transactions
387
Medicare Patients
5,016
Medicare Billing
$386,763
Payment Breakdown by Category
Food & Beverage$9,335 (79.3%)
Travel$1,212 (10.3%)
Other$1,123 (9.5%)
Education$103.82 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,335 | 379 | 79.3% |
| Travel and Lodging | $1,212 | 4 | 10.3% |
| Grant | $1,123 | 1 | 9.5% |
| Education | $103.82 | 3 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic Vascular, Inc. | $3,396 | 31 | $0 (2020) |
| Boston Scientific Corporation | $1,806 | 53 | $0 (2024) |
| BIOTRONIK INC. | $1,146 | 43 | $0 (2024) |
| ABIOMED | $970.05 | 22 | $0 (2024) |
| Abbott Laboratories | $963.64 | 39 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $417.13 | 27 | $0 (2024) |
| Medtronic, Inc. | $307.78 | 8 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $276.35 | 39 | $0 (2024) |
| Amgen Inc. | $215.19 | 14 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $198.20 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,130 | 35 | ABIOMED ($486.62) |
| 2023 | $987.95 | 35 | ABIOMED ($191.90) |
| 2022 | $673.31 | 21 | Boston Scientific Corporation ($258.51) |
| 2021 | $722.00 | 22 | Medtronic, Inc. ($288.59) |
| 2020 | $2,370 | 54 | Medtronic Vascular, Inc. ($1,760) |
| 2019 | $3,204 | 74 | Medtronic Vascular, Inc. ($1,549) |
| 2018 | $1,454 | 74 | BIOTRONIK INC. ($344.26) |
| 2017 | $1,233 | 72 | BIOTRONIK INC. ($341.95) |
All Payment Transactions
387 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Abbott Laboratories | GALLANT (Device) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/18/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $47.20 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/18/2024 | Boston Scientific Corporation | ROTAPRO (Device) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: ROTAPRO_IC | ||||||
| 12/16/2024 | ShockWave Medical, Inc | Shockwave Intravascular Lithotripsy (IVL) System with the Shockwave E8 Peripher (Device) | Food and Beverage | In-kind items and services | $27.61 | General |
| Category: Lithoplasty | ||||||
| 12/11/2024 | Boston Scientific Corporation | ACCOLADE SR (Device) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: ACCOLADE_CRM | ||||||
| 11/26/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $270.14 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/15/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $21.38 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/13/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $14.70 | General |
| Category: Cardiovascular | ||||||
| 11/11/2024 | BIOTRONIK INC. | Acticor 7 VR-T DX (Device) | Food and Beverage | In-kind items and services | $26.74 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/04/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $58.12 | General |
| Category: General - Tachy_CRM | ||||||
| 10/22/2024 | Medtronic, Inc. | MICRA (Device) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: Pacemakers | ||||||
| 10/17/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $12.62 | General |
| Category: CDS broad portfolio offering_CRM | ||||||
| 09/26/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/06/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $30.74 | General |
| Category: CDS broad portfolio offering_CRM | ||||||
| 09/03/2024 | Boston Scientific Corporation | AVVIGO Guidance System (Device) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: AVVIGO_IC | ||||||
| 08/07/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: CDS broad portfolio offering_CRM | ||||||
| 07/30/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/10/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $8.62 | General |
| Category: General - Brady_CRM | ||||||
| 06/19/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $20.56 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/18/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $28.24 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/13/2024 | Boston Scientific Corporation | AVVIGO Guidance System (Device) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: AVVIGO_IC | ||||||
| 05/31/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: CDS broad portfolio offering_CRM | ||||||
| 05/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/30/2024 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $33.76 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,310 | 1,452 | $402,023 | $98,387 |
| 2022 | 20 | 944 | 1,029 | $369,717 | $89,600 |
| 2021 | 19 | 1,301 | 1,461 | $370,308 | $92,309 |
| 2020 | 24 | 1,461 | 1,662 | $420,518 | $106,467 |
Total Patients
5,016
Total Services
5,604
Medicare Billing
$386,763
Procedure Codes
88
All Medicare Procedures & Services
88 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 195 | 206 | $130,810 | $28,652 | 21.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 140 | 173 | $64,356 | $21,204 | 32.9% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 21 | 32 | $52,193 | $10,363 | 19.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 60 | 60 | $31,980 | $9,582 | 30.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 112 | 112 | $20,160 | $5,264 | 26.1% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 31 | 32 | $23,168 | $5,029 | 21.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 28 | 28 | $14,756 | $3,160 | 21.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 394 | 451 | $10,373 | $2,757 | 26.6% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 16 | 16 | $13,072 | $2,495 | 19.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 23 | 23 | $6,394 | $1,759 | 27.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 13 | 13 | $3,744 | $1,451 | 38.8% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 24 | 27 | $8,181 | $1,443 | 17.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $4,697 | $961.75 | 20.5% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Office | 2023 | 24 | 24 | $4,416 | $936.67 | 21.2% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 2023 | 15 | 30 | $2,072 | $729.58 | 35.2% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 64 | 66 | $2,340 | $610.56 | 26.1% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 22 | 24 | $1,680 | $447.35 | 26.6% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Office | 2023 | 24 | 24 | $3,312 | $434.19 | 13.1% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 25 | 25 | $1,296 | $422.74 | 32.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 32 | 39 | $2,028 | $405.27 | 20.0% |
| 93242 | Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 24 | 24 | $743.04 | $212.94 | 28.7% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 12 | 12 | $252.00 | $66.72 | 26.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 147 | 182 | $67,704 | $22,603 | 33.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 149 | 156 | $99,060 | $20,718 | 20.9% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2022 | 28 | 40 | $63,304 | $13,239 | 20.9% |
About Dr. Patrick Bergin, M.D
Dr. Patrick Bergin, M.D is a Cardiovascular Disease healthcare provider based in Eugene, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/17/2012. The National Provider Identifier (NPI) number assigned to this provider is 1225309685.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Bergin, M.D has received a total of $11,775 in payments from pharmaceutical and medical device companies, with $1,130 received in 2024. These payments were reported across 387 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($9,335).
As a Medicare-enrolled provider, Bergin has provided services to 5,016 Medicare beneficiaries, totaling 5,604 services with total Medicare billing of $386,763. Data is available for 4 years (2020–2023), covering 88 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Eugene, OR
- Active Since 01/17/2012
- Last Updated 05/11/2016
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1225309685
Products in Payments
- CoreValve Evolut (Device) $2,514
- 3F (Device) $1,123
- Impella (Device) $970.05
- ELIQUIS (Drug) $393.24
- ROTABLATOR (Device) $347.90
- ENTRESTO (Drug) $308.64
- SYNERGY (Device) $291.70
- Corlanor (Drug) $215.19
- Comet (Device) $159.22
- GUIDEZILLA (Device) $147.17
- ASSURITY (Device) $145.74
- Quadra Assura CRT Defibrillator (Device) $142.70
- LifeVest (Device) $136.98
- XARELTO (Drug) $131.70
- AVVIGO Guidance System (Device) $124.54
- OTHER- BSC PRODUCT NOT LISTED (Device) $118.12
- Xience Sierra Coronary Stent System (Device) $116.88
- BYSTOLIC (Drug) $113.98
- BRILINTA (Drug) $112.49
- LEQVIO (Drug) $108.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.